| 5 min read
Biomarkers could help researchers identify patients most likely to respond to psychiatric drugs, but translating early promise into clinical success remains a challenge.
| 4 min read
From interpreting conflicting laboratory results to modelling underrepresented populations, virtual hearts could help researchers assess cardiac safety earlier in drug development.
| 4 min read
FDA guidance, trial results, glioblastoma studies, and more led the news this week.
| 3 min read
A new approach to protein degradation improved mitochondrial function and neuronal survival in cell models of several mitochondrial disorders.
| 2 min read
Researchers tested a new antisense oligonucleotide therapy that turns the maternal healthy genes back on to target the underlying cause of disease.News
| 4 min read
Researchers are beginning to uncover differences in brain metabolism and cognitive performance among people with PMOS, but it’s still unknown what drives these changes and whether they have long-term consequences.
| 2 min read
The multi-omics data on nearly half a million tumor cells showed that even cells with almost identical genetic makeup can show radically different behavior.
| 5 min read
Clinical trial updates, regulatory approvals, and more led the news this week.
| 4 min read
BCG vaccination reduced tau pathology and neuroinflammation in mice, prompting researchers to investigate whether trained immunity could inform future treatments for Alzheimer’s disease.
| 3 min read
Bacterial genomes recovered from discarded DNA sequencing data could help researchers investigate whether microbes contribute to aggressive prostate cancer.
| 4 min read
A machine learning-based screen identified SRSF1 as a potential target for reversing several hallmarks of aging without erasing cell identity, with further testing revealing benefits in aged mice.
Cancer Research News
IVDR-certified CytoCell probes for IGH and ATM extend FISH in CLL and myeloma, filling gaps where sequencing turnaround and structural detection fall short
OGT's first dedicated fusion MRD NGS panel targets the roughly one-quarter of AML cases where RNA fusion transcripts, not DNA mutations, define residual disease
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Explore how surface plasmon resonance can reveal binding kinetics, epitope relationships, and receptor interactions to guide antibody lead optimization.
Explore how enzymatic DNA synthesis can support longer, more complex constructs for genome editing, mRNA, and synthetic biology workflows.
